Mode
Text Size
Log in / Sign up
N/A N=28 Randomized Single-blind Treatment

Comparison of Two Techniques of Combination Therapy for Treatment of Obstructive Sleep Apnea (OSA)

Treatment for Obstructive Sleep Apnea

Enrolled (actual)
28
Serious AEs
0.0%
Results posted
Apr 2021
Primary outcome: Primary: Apnea-Hypopnea Index — 4.1; 3.6 episodes/hour

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Nuance Pro (Device); autoPAP (Device); TAP PAP (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Joseph Adame
Primary completion
Feb 2019

Outcome Measures

OutcomeResultp-value
PRIMARY
Apnea-Hypopnea Index
4.1; 3.6
PRIMARY
PAP Pressure
9.6; 8.6
PRIMARY
Leaks
15.1; 16.7
PRIMARY
Hours of Use
6.0; 5.9
PRIMARY
Epworth Sleepiness Scale (ESS)
5.5; 5.8
PRIMARY
Functional Outcomes Sleep Questionnaire (FOSQ)
36.3; 36.2
PRIMARY
Intolerance Questionnaire
2.7; 3.4

Summary

To study the effects of two combination therapies for patients with obstructive sleep apnea (OSA) who have been both intolerant to Positive Airway Pressure (PAP) therapy and sub-therapeutic to oral appliance therapy. Hypothesis 1. There is a difference between Continuous Positive Airway Pressure (CPAP) vs CPAP/Oral Appliance (OA) connect vs CPAP/OA disconnected in terms of: 1. Apnea Hypopnea Index (AHI) reduction 2. Amount of side effects 3. Amount of Leaks 4. Hours of use (compliance) 5. CPAP pressure 2. There is a difference between connected and disconnected for the following symptoms: 1. Epworth sleepiness Scale (ESS) 2. Functional Outcomes of Sleep Questionnaire (FOSQ) 3. Side effects Study Design - randomized prospective parallel

Eligibility Criteria

Inclusion Criteria: Baseline diagnosis AHI > or = 5 plus ESS . or = 10.

  • PAP Intolerance
  • Partial Response to oral appliance therapy: AHI > 5
  • Age: > 18 Exclusion Criteria: History of daily use of alcohol, narcotics or Central Nervous System (CNS) depressants.
  • Diagnosis of Central Sleep Apnea
  • Pregnancy
  • Edentulous
  • Prisoners
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04029311). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search